|
|
||||||||
,§
,¶
,§
,§,¶
Departments of
*
Medicine,
Immunology, and
Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, CO 80262; and Departments of
§
Medicine and
¶
Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206
Chronic beryllium disease (CBD) is caused by beryllium exposure and
is characterized by granulomatous inflammation with accumulation of
CD4+ T cells in the lung. We analyzed TCR ß-chain and
-chain genes expressed by these CD4+ T cells. In the
lungs of individual patients, as well as among four of five CBD
patients studied, different oligoclonal expansions within the Vß3
subset were found to express homologous or even identical CDR3 amino
acid sequences. These related expansions were specific for CBD
patients, were compartmentalized to lung, and persisted at high
frequency in patients with active disease. Limiting dilution cloning
and analysis of coexpressed TCR
-chain genes confirmed that these
TCRs were selectively expanded by a common Ag involving beryllium.
Overall, homologous TCR ß- and
-chains showed identical V regions
and invariant charged residues within the CDR3 but considerable
variability in TCRJ usage. Remarkably, CBD patients expressing nearly
identical TCRs did not share common HLA-DRB1 or DQ alleles. These
results implicate particular CD4+ cells in the pathogenesis
of CBD and provide insight into how beryllium is recognized in human
disease.
This article has been cited by other articles:
![]() |
D. G. Mack, A. K. Lanham, B. E. Palmer, L. A. Maier, T. H. Watts, and A. P. Fontenot 4-1BB Enhances Proliferation of Beryllium-Specific T Cells in the Lung of Subjects with Chronic Beryllium Disease J. Immunol., September 15, 2008; 181(6): 4381 - 4388. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Palmer, D. G. Mack, A. K. Martin, M. Gillespie, M. M. Mroz, L. A. Maier, and A. P. Fontenot Up-Regulation of Programmed Death-1 Expression on Beryllium-Specific CD4+ T Cells in Chronic Beryllium Disease J. Immunol., February 15, 2008; 180(4): 2704 - 2712. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G. Luzina, N. W. Todd, A. T. Iacono, and S. P. Atamas Roles of T lymphocytes in pulmonary fibrosis J. Leukoc. Biol., February 1, 2008; 83(2): 237 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Fontenot, T. S. Keizer, M. McCleskey, D. G. Mack, R. Meza-Romero, J. Huan, D. M. Edwards, Y. K. Chou, A. A. Vandenbark, B. Scott, et al. Recombinant HLA-DP2 Binds Beryllium and Tolerizes Beryllium-Specific Pathogenic CD4+ T Cells J. Immunol., September 15, 2006; 177(6): 3874 - 3883. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Bill, D. G. Mack, M. T. Falta, L. A. Maier, A. K. Sullivan, F. G. Joslin, A. K. Martin, B. M. Freed, B. L. Kotzin, and A. P. Fontenot Beryllium Presentation to CD4+ T Cells Is Dependent on a Single Amino Acid Residue of the MHC Class II {beta}-Chain J. Immunol., November 15, 2005; 175(10): 7029 - 7037. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Sullivan, P. L. Simonian, M. T. Falta, J. D. Mitchell, G. P. Cosgrove, K. K. Brown, B. L. Kotzin, N. F. Voelkel, and A. P. Fontenot Oligoclonal CD4+ T Cells in the Lungs of Patients with Severe Emphysema Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 590 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. K. Chou, D. M. Edwards, A. D. Weinberg, A. A. Vandenbark, B. L. Kotzin, A. P. Fontenot, and G. G. Burrows Activation Pathways Implicate Anti-HLA-DP and Anti-LFA-1 Antibodies as Lead Candidates for Intervention in Chronic Berylliosis J. Immunol., April 1, 2005; 174(7): 4316 - 4324. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Facco, L. Trentin, L. Nicolardi, M. Miorin, E. Scquizzato, D. Carollo, I. Baesso, M. Bortoli, R. Zambello, G. Marcer, et al. T cells in the lung of patients with hypersensitivity pneumonitis accumulate in a clonal manner J. Leukoc. Biol., May 1, 2004; 75(5): 798 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Amicosante, F. Berretta, A. Franchi, P. Rogliani, C. Dotti, M. Losi, R. Dweik, and C. Saltini HLA-DP-unrestricted TNF-{alpha} release in beryllium-stimulated peripheral blood mononuclear cells Eur. Respir. J., November 1, 2002; 20(5): 1174 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Fontenot, L. A. Maier, S. J. Canavera, T. B. Hendry-Hofer, M. Boguniewicz, E. A. Barker, L. S. Newman, and B. L. Kotzin Beryllium Skin Patch Testing to Analyze T Cell Stimulation and Granulomatous Inflammation in the Lung J. Immunol., April 1, 2002; 168(7): 3627 - 3634. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. ROSSMAN, J. STUBBS, C. W. LEE, E. ARGYRIS, E. MAGIRA, and D. MONOS Human Leukocyte Antigen Class II Amino Acid Epitopes . Susceptibility and Progression Markers for Beryllium Hypersensitivity Am. J. Respir. Crit. Care Med., March 15, 2002; 165(6): 788 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Saltini, L. Richeldi, M. Losi, M. Amicosante, C. Voorter, E. van den Berg-Loonen, R.A. Dweik, H.P. Wiedemann, D.C. Deubner, and C. Tinelli Major histocompatibility locus genetic markers of beryllium sensitization and disease Eur. Respir. J., October 1, 2001; 18(4): 677 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.A. Maier, R.T. Sawyer, S.S. Tinkle, L.A. Kittle, E.A. Barker, R. Balkissoon, C. Rose, and L.S. Newman IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis Eur. Respir. J., March 1, 2001; 17(3): 403 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lombardi, C. Germain, J. Uren, M. T. Fiorillo, R. M. du Bois, W. Jones-Williams, C. Saltini, R. Sorrentino, and R. Lechler HLA-DP Allele-Specific T Cell Responses to Beryllium Account for DP-Associated Susceptibility to Chronic Beryllium Disease J. Immunol., March 1, 2001; 166(5): 3549 - 3555. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Fontenot, M. Torres, W. H. Marshall, L. S. Newman, and B. L. Kotzin Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease PNAS, October 23, 2000; (2000) 220430797. [Abstract] [Full Text] |
||||
![]() |
A. P. Fontenot, M. Torres, W. H. Marshall, L. S. Newman, and B. L. Kotzin Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease PNAS, November 7, 2000; 97(23): 12717 - 12722. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |